norethindrone has been researched along with Neoplasms, Cystic, Mucinous, and Serous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koskela-Niska, V; Lyytinen, H; Pukkala, E; Riska, A; Ylikorkala, O | 1 |
1 other study(ies) available for norethindrone and Neoplasms, Cystic, Mucinous, and Serous
Article | Year |
---|---|
Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy - a nationwide study.
Topics: Aged; Aged, 80 and over; Confidence Intervals; Estradiol; Estrogen Replacement Therapy; Female; Finland; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Cystic, Mucinous, and Serous; Norethindrone; Norethindrone Acetate; Ovarian Neoplasms; Postmenopause; Progestins; Risk Assessment; Time Factors | 2013 |